Esketamine Tops Quetiapine in Treatment-Resistant Depression

(MedPage Today) -- Esketamine nasal spray (Spravato) led to better remission rates compared with extended-release quetiapine (Seroquel XR) in patients with treatment-resistant depression when used in combination with ongoing treatment, the randomized...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news